A Delaware federal judge has reopened Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing five patents through competing gout flare drug Mitigare, ruling Wednesday that a second amended complaint contains sufficiently detailed allegations.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.